Cargando…

Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema

BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients’ health and well‐being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that ‘long‐term control of eczema’ is measured in all clinical trials 3 months or l...

Descripción completa

Detalles Bibliográficos
Autores principales: Howells, L., Thomas, K.S., Sears, A.V., Nasr, I., Wollenberg, A., Schuttelaar, M.L.A., Romeijn, G.L.E., Paller, A.S., Mueller, K., Doytcheva, K., Kataoka, Y., Daguze, J., Barbarot, S., von Kobyletzki, L.B., Beckman, L., Ratib, S., Cowdell, F., Santer, M., Chalmers, J.R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594222/
https://www.ncbi.nlm.nih.gov/pubmed/30720903
http://dx.doi.org/10.1111/jdv.15475
_version_ 1783430206672863232
author Howells, L.
Thomas, K.S.
Sears, A.V.
Nasr, I.
Wollenberg, A.
Schuttelaar, M.L.A.
Romeijn, G.L.E.
Paller, A.S.
Mueller, K.
Doytcheva, K.
Kataoka, Y.
Daguze, J.
Barbarot, S.
von Kobyletzki, L.B.
Beckman, L.
Ratib, S.
Cowdell, F.
Santer, M.
Chalmers, J.R.
author_facet Howells, L.
Thomas, K.S.
Sears, A.V.
Nasr, I.
Wollenberg, A.
Schuttelaar, M.L.A.
Romeijn, G.L.E.
Paller, A.S.
Mueller, K.
Doytcheva, K.
Kataoka, Y.
Daguze, J.
Barbarot, S.
von Kobyletzki, L.B.
Beckman, L.
Ratib, S.
Cowdell, F.
Santer, M.
Chalmers, J.R.
author_sort Howells, L.
collection PubMed
description BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients’ health and well‐being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that ‘long‐term control of eczema’ is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema. OBJECTIVES: To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term. METHODS: Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups. RESULTS: Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty‐two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered. CONCLUSIONS: This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions.
format Online
Article
Text
id pubmed-6594222
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-65942222019-07-10 Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema Howells, L. Thomas, K.S. Sears, A.V. Nasr, I. Wollenberg, A. Schuttelaar, M.L.A. Romeijn, G.L.E. Paller, A.S. Mueller, K. Doytcheva, K. Kataoka, Y. Daguze, J. Barbarot, S. von Kobyletzki, L.B. Beckman, L. Ratib, S. Cowdell, F. Santer, M. Chalmers, J.R. J Eur Acad Dermatol Venereol Allergy and Eczema BACKGROUND: Atopic eczema (also known as eczema) is a chronic, inflammatory skin condition that often afflicts patients’ health and well‐being. The Harmonising Outcome Measures for Eczema (HOME) initiative recommends that ‘long‐term control of eczema’ is measured in all clinical trials 3 months or longer in duration. However, little has been published on what eczema control means to those living with or treating atopic eczema. OBJECTIVES: To (i) develop understanding of what eczema control means to patients, carers and clinicians and (ii) explore the feasibility and acceptability of different ways of measuring eczema control in the long term. METHODS: Online focus groups explored patients/carers experiences in the UK, the United States, the Netherlands, France, Sweden and Japan, and an international online survey gathered views of clinicians. The framework method was used to analyse the focus groups, and thematic analysis was used to analyse survey data. All findings were integrated into a theoretical framework to create overarching themes that cut across these diverse groups. RESULTS: Eight focus groups with patients (16 years+) and eight groups with carers of children took place (N = 97). Sixty‐two people took part in the survey. Eczema control was described as a multifaceted construct involving changes in disease activity, the treatment and management of the condition and psychological, social and physical functioning. Patient/carer measurement allows personal accounts and frequent measurement, whilst clinician measurement was deemed less subjective. The burden on patients/carers and issues for analysing and interpreting data should be considered. CONCLUSIONS: This study formed the basis of judging the content validity and feasibility of measurement instruments/methods to assess control of eczema in clinical trials. This online approach to an international qualitative study is an example of how core outcome set developers with limited resources can engage with multiple stakeholder groups on an international basis to inform consensus meeting discussions. John Wiley and Sons Inc. 2019-04-08 2019-06 /pmc/articles/PMC6594222/ /pubmed/30720903 http://dx.doi.org/10.1111/jdv.15475 Text en © 2019 The Authors. Journal of the European Academy of Dermatology and Venereology published by John Wiley & Sons Ltd on behalf of European Academy of Dermatology and Venereology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Allergy and Eczema
Howells, L.
Thomas, K.S.
Sears, A.V.
Nasr, I.
Wollenberg, A.
Schuttelaar, M.L.A.
Romeijn, G.L.E.
Paller, A.S.
Mueller, K.
Doytcheva, K.
Kataoka, Y.
Daguze, J.
Barbarot, S.
von Kobyletzki, L.B.
Beckman, L.
Ratib, S.
Cowdell, F.
Santer, M.
Chalmers, J.R.
Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
title Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
title_full Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
title_fullStr Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
title_full_unstemmed Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
title_short Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
title_sort defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
topic Allergy and Eczema
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6594222/
https://www.ncbi.nlm.nih.gov/pubmed/30720903
http://dx.doi.org/10.1111/jdv.15475
work_keys_str_mv AT howellsl definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT thomasks definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT searsav definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT nasri definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT wollenberga definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT schuttelaarmla definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT romeijngle definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT palleras definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT muellerk definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT doytchevak definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT kataokay definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT daguzej definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT barbarots definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT vonkobyletzkilb definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT beckmanl definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT ratibs definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT cowdellf definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT santerm definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT chalmersjr definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema
AT definingandmeasuringeczemacontrolaninternationalqualitativestudytoexploretheviewsofthoselivingwithandtreatingatopiceczema